Yun H, Kim S, Kwon Y, Park K
Antioxidants (Basel). 2024; 13(10).
PMID: 39456416
PMC: 11505237.
DOI: 10.3390/antiox13101162.
Song Y, Wang X, Sun Y, Yu N, Tian Y, Han J
Int J Biol Sci. 2024; 20(13):5070-5086.
PMID: 39430237
PMC: 11489176.
DOI: 10.7150/ijbs.99804.
Manjunath M, Ravindran F, Sharma S, Siddiqua H, Raghavan S, Choudhary B
Int J Mol Sci. 2024; 25(12).
PMID: 38928195
PMC: 11203414.
DOI: 10.3390/ijms25126485.
Carvalho L, Noma I, Uehara A, Siena A, Osaki L, Mori M
Antioxidants (Basel). 2024; 13(5).
PMID: 38790661
PMC: 11118096.
DOI: 10.3390/antiox13050555.
Takasaki T, Hamabe Y, Touchi K, Khandakar G, Ueda T, Okada H
Oxid Med Cell Longev. 2024; 2024:7683793.
PMID: 38500550
PMC: 10948229.
DOI: 10.1155/2024/7683793.
Comparative Analysis of Inhibitor Binding to Peroxiredoxins from Candidatus Liberibacter asiaticus and Its Host Citrus sinensis.
Gupta D, Lonare S, Rani R, Singh A, Ghosh D, Tomar S
Appl Biochem Biotechnol. 2023; 196(8):5334-5353.
PMID: 38157153
DOI: 10.1007/s12010-023-04798-y.
Marine Natural Compound (Neviotin A) Displays Anticancer Efficacy by Triggering Transcriptomic Alterations and Cell Death in MCF-7 Cells.
Saquib Q, Schwaiger S, Alilou M, Ahmed S, Siddiqui M, Ahmad J
Molecules. 2023; 28(17).
PMID: 37687120
PMC: 10488820.
DOI: 10.3390/molecules28176289.
Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.
Rafe Hatshan M, Saquib Q, Siddiqui M, Faisal M, Ahmad J, Al-Khedhairy A
Int J Mol Sci. 2023; 24(11).
PMID: 37298090
PMC: 10252622.
DOI: 10.3390/ijms24119141.
p66Shc in Cardiovascular Pathology.
Haslem L, Hays J, Hays F
Cells. 2022; 11(11).
PMID: 35681549
PMC: 9180016.
DOI: 10.3390/cells11111855.
Pink1/PARK2/mROS-Dependent Mitophagy Initiates the Sensitization of Cancer Cells to Radiation.
Yu L, Yang X, Li X, Qin L, Xu W, Cui H
Oxid Med Cell Longev. 2021; 2021:5595652.
PMID: 34306311
PMC: 8279859.
DOI: 10.1155/2021/5595652.
Integrative analysis the characterization of peroxiredoxins in pan-cancer.
Gao L, Meng J, Yue C, Wu X, Su Q, Wu H
Cancer Cell Int. 2021; 21(1):366.
PMID: 34246267
PMC: 8272277.
DOI: 10.1186/s12935-021-02064-x.
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance.
Huang H, Zhang S, Li Y, Liu Z, Mi L, Cai Y
Nat Commun. 2021; 12(1):3720.
PMID: 34140524
PMC: 8211793.
DOI: 10.1038/s41467-021-24108-6.
Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development.
Sun H, Ren C, Gong Y, Xie D, Kwon T
Oncol Lett. 2021; 21(6):465.
PMID: 33907575
PMC: 8063228.
DOI: 10.3892/ol.2021.12726.
Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin.
Gupta N, Verma K, Nalla S, Kulshreshtha A, Lall R, Prasad S
Molecules. 2020; 25(22).
PMID: 33217990
PMC: 7698794.
DOI: 10.3390/molecules25225390.
Overexpression and biological function of PRDX6 in human cervical cancer.
Hu X, Lu E, Pan C, Xu Y, Zhu X
J Cancer. 2020; 11(9):2390-2400.
PMID: 32201510
PMC: 7066013.
DOI: 10.7150/jca.39892.
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer.
Lu E, Hu X, Pan C, Chen J, Xu Y, Zhu X
J Cancer. 2020; 11(5):1170-1181.
PMID: 31956363
PMC: 6959069.
DOI: 10.7150/jca.37147.
Understanding of ROS-Inducing Strategy in Anticancer Therapy.
Kim S, Kim H, Seo Y
Oxid Med Cell Longev. 2020; 2019:5381692.
PMID: 31929855
PMC: 6939418.
DOI: 10.1155/2019/5381692.
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements.
Aggarwal V, Tuli H, Varol A, Thakral F, Yerer M, Sak K
Biomolecules. 2019; 9(11).
PMID: 31766246
PMC: 6920770.
DOI: 10.3390/biom9110735.
Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.
Bai B, Lin Y, Hu J, Wang H, Li L, Zhao S
Oncol Rep. 2019; 41(3):1539-1548.
PMID: 30747220
PMC: 6365706.
DOI: 10.3892/or.2019.6977.
Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.
S Romanello K, K L Teixeira K, Silva J, Nagamatsu S, Bezerra M, Domingos I
PLoS One. 2018; 13(12):e0208316.
PMID: 30521599
PMC: 6283586.
DOI: 10.1371/journal.pone.0208316.